pCDH-EF1a-eFFly-eGFP Citations (3)

Originally described in: Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia.
Sandhofer N, Metzeler KH, Rothenberg M, Herold T, Tiedt S, Groiss V, Carlet M, Walter G, Hinrichsen T, Wachter O, Grunert M, Schneider S, Subklewe M, Dufour A, Frohling S, Klein HG, Hiddemann W, Jeremias I, Spiekermann K Leukemia. 2015 Apr;29(4):828-38. doi: 10.1038/leu.2014.305. Epub 2014 Oct 17. PubMed Journal

---

Articles Citing pCDH-EF1a-eFFly-eGFP

Articles
Endogenous TCR promotes in vivo persistence of CD19-CAR-T cells compared to a CRISPR/Cas9-mediated TCR knockout CAR. Stenger D, Stief TA, Kauferle T, Willier S, Rataj F, Schober K, Vick B, Lotfi R, Wagner B, Grunewald TGP, Kobold S, Busch DH, Jeremias I, Blaeschke F, Feuchtinger TF. Blood. 2020 Jun 1. pii: 460603. doi: 10.1182/blood.2020005185. PubMed
Therapeutic targeting of PRAME with mTCRCAR T cells in acute myeloid leukemia. Kirkey DC, Loeb AM, Castro S, McKay CN, Perkins L, Pardo L, Leonti AR, Tang TT, Loken MR, Brodersen LE, Loeb KR, Scheinberg DA, Le Q, Meshinchi S. Blood Adv. 2023 Apr 11;7(7):1178-1189. doi: 10.1182/bloodadvances.2022008304. PubMed
CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target. Le Q, Hadland B, Smith JL, Leonti A, Huang BJ, Ries R, Hylkema TA, Castro S, Tang TT, McKay CN, Perkins L, Pardo L, Sarthy J, Beckman AK, Williams R, Idemmili R, Furlan S, Ishida T, Call L, Srivastava S, Loeb AM, Milano F, Imren S, Morris SM, Pakiam F, Olson JM, Loken MR, Brodersen L, Riddell SR, Tarlock K, Bernstein ID, Loeb KR, Meshinchi S. J Clin Invest. 2022 Nov 15;132(22):e157101. doi: 10.1172/JCI157101. PubMed

If you have published an article using this material, please email us at to have your article added to this page.